An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs

American Journal of Epidemiology

Volumn 171, Issue 8, 2010, Pages 924-931

  Chi, Benjamin H ^a,b   Cantrell, Ronald A ^a,b   Mwango, Albert ^c   Westfall, Andrew O ^a,b   Mutale, Wilbroad ^a,d   Limbada, Mohammed ^a   Mulenga, Lloyd B ^a   Vermund, Sten H ^a,e   Stringer, Jeffrey S A ^a,b  

^a CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c MINISTRY OF HEALTH   (Zambia)

^d UNIVERSITY OF ZAMBIA   (Zambia)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

Africa; Antiretroviral therapy, highly active; Follow up studies; HIV; Patient dropouts; Zambia

Indexed keywords

ANTIRETROVIRUS AGENT;

DATABASE; DRUG; EMPIRICAL ANALYSIS; HEALTH RISK; HEALTH WORKER; HUMAN IMMUNODEFICIENCY VIRUS; MEDICINE; SENSITIVITY ANALYSIS; STANDARDIZATION;

ADULT; ARTICLE; COHORT ANALYSIS; FOLLOW UP; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PATIENT CARE;

ADULT; ANTI-HIV AGENTS; APPOINTMENTS AND SCHEDULES; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; DRUG MONITORING; HIV INFECTIONS; HUMANS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MEDICATION ADHERENCE; PATIENT DROPOUTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TIME FACTORS; ZAMBIA;

LUSAKA [ZAMBIA]; ZAMBIA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77950850796     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq008     Document Type: Article

References (27)

1. Joint United Nations Programme on HIV/AIDS. Report on the Global AIDS Epidemic. Geneva, Switzerland: World Health Organization; 2008.
2. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries. Lancet. 2006;367(9513):817-824.
3. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: A systematic review [electronic article]. PLoS Med. 2007;4(10):e298. (Pubitemid 350035458)
4. Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006;296(7):782-793. (Pubitemid 44223102)
5. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298(16):1888-1899. (Pubitemid 350005233)
6. Chi BH, Cantrell RA, Zulu I, et al. Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia. Int J Epidemiol. 2009;38(3):746-756.
7. Chi BH, Sinkala M, Stringer EM, et al. Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine. AIDS. 2007;21(8):957-964. (Pubitemid 46684327)
8. Chi BH, Giganti M, Mulenga PL, et al. CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2009;52(1):125-131.
9. Cantrell RA, Sinkala M, Megazinni K, et al. A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2008;49(2):190-195.
10. Goldman JD, Cantrell RA, Mulenga LB, et al. Simple adherence assessments to predict virologic failure among HIVinfected adults with discordant immunologic and clinical responses to antiretroviral therapy. AIDS Res Hum Retroviruses. 2008;24(8):1031-1035.
11. Mulenga LB, Kruse G, Lakhi S, et al. Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. AIDS. 2008;22(14): 1821-1827.
12. Calmy A, Pinoges L, Szumilin E, et al. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS. 2006;20(8):1163-1169. (Pubitemid 43786105)
13. Ferradini L, Jeannin A, Pinoges L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: An effectiveness assessment. Lancet. 2006;367(9519):1335-1342.
14. Yu JK, Chen SC, Wang KY, et al. True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ. 2007;85(7):550-554. (Pubitemid 47041634)
15. Brinkhof MW, Dabis F, Myer L, et al. Early loss of HIVinfected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008; 86(7):559-567. (Pubitemid 351931216)
16. Wools-Kaloustian K, Kimaiyo S, Diero L, et al. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS. 2006; 20(1):41-48. (Pubitemid 41818113)
17. Zambian Ministry of Health. Antiretroviral Therapy for Chronic HIV Infection in Adults and Adolescents: New ART Protocols, May 2007. Lusaka, Zambia: Printech Press; 2007.
18. World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents in Resource-Limited Settings: Towards Universal Access. Geneva, Switzerland: World Health Organization; 2006.
19. World Health Organization. Antiretroviral Therapy of HIV Infection in Infants and Children in Resource-Limited Settings: Towards Universal Access. Geneva, Switzerland: World Health Organization; 2006.
20. Fusco H, Hubschman T, Mweeta V, et al. Electronic patient tracking supports rapid expansion of HIV care and treatment in resource-constrained settings [abstract]. (Abstract MoPe11.2C37). Presented at the 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, Brazil, July 24-27, 2005.
21. Krebs DW, Chi BH, Mulenga Y, et al. Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care. 2008;20(3):311-317. (Pubitemid 351451247)
22. Hoover DR, Muñoz A, Carey V, et al. The unseen sample in cohort studies: estimation of its size and effect. Multicenter AIDS Cohort Study. Stat Med. 1991;10(12):1993-2003.
23. Kelly MJ, Dunstan FD, Lloyd K, et al. Evaluating cutpoints for the MHI-5 and MCS using the GHQ-12: A comparison of five different methods [electronic article]. BMC Psychiatry. 2008; 8:10.
24. Geng EH, Emenyonu N, Bwana MB, et al. Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA. 2008;300(5):506-507.
25. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis [electronic article]. PLoS One. 2009;4(6): e5790.
26. Lawn SD, Harries AD, Anglaret X, et al. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22(15):1897-1908.
27. Forster M, Bailey C, Brinkhof MW, et al. Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resourcelimited settings. Bull World Health Organ. 2008;86(12): 939-947.